Advancing Immunology Therapy: Early Prediction of Skin Cancer Patients’ Chances of Responding to Treatment and Trials on Prednisone and Sirolimus for Kidney Transplant Recipients

Reading time: 5 minutes Joycelyn Ghansah, MA, MPH Active treatments like immunotherapy are used for various cancers, including melanoma, commonly known as skin cancer. Unfortunately, only about half of the patients respond to this type of treatment. Current research focuses on early prediction of skin cancers and identifying which patients are likely to respond positively... Continue Reading →

July 30, 2025 0

The link between cancer and gut microbiome

Reading time: 7 minutes Oluoma Vivian Aneke The human microbiota is comprised of trillions of microorganisms that have both bacterial and viral origins. They work together with the immune system to fight the invasion of pathogens. They also help to carry out metabolic functions, extract energy like short-chain fatty acids, and source essential nutrients and... Continue Reading →

July 23, 2025 0

Cancer After Childbirth: An Uncommon But Possible Phenomenon

Reading time: 7 minutes Jessica Desamero, PhD Recently, I noticed I knew a good number of individuals that have developed cancer while pregnant or shortly after giving birth. Although there’s no direct correlation between pregnancy and the risk of cancer, could there be an indirect link? After researching potential causes, I found that pregnancy-associated cancer... Continue Reading →

July 16, 2025 0

How Cancer Cells Steal Energy: The Story of Mitochondrial Transfer

Reading time: 4 minutes Hema Saranya Ilamathi Cancer is not just a disease of uncontrolled cell growth—it's a master in cellular manipulation and survival. Scientists have long known that cancer cells behave very differently from normal ones. They reprogram themselves to survive in harsh environments, change the way they use nutrients, and even manipulate their... Continue Reading →

July 9, 2025 0

Targeting the undruggable: Updates in KRAS directed therapies

Reading time: 5 minutes Chris Wang Since its discovery in 1982, therapies targeting the mutated KRAS oncogene have long eluded cancer researchers. KRAS has been considered an undruggable target for decades due to lack of a binding pocket where a drug could fit.1 However, the need for KRAS targeting therapies is severely needed as KRAS... Continue Reading →

July 2, 2025 0

Up ↑

Category: July 2025

Advancing Immunology Therapy: Early Prediction of Skin Cancer Patients’ Chances of Responding to Treatment and Trials on Prednisone and Sirolimus for Kidney Transplant Recipients

The link between cancer and gut microbiome

Cancer After Childbirth: An Uncommon But Possible Phenomenon

How Cancer Cells Steal Energy: The Story of Mitochondrial Transfer

Targeting the undruggable: Updates in KRAS directed therapies

Categories

Follow OncoBites via Email

Tags

Follow OncoBites on Twitter